Recursion Pharmaceuticals Inc.
Clinical trials sponsored by Recursion Pharmaceuticals Inc., explained in plain language.
-
New drug aims to shrink polyps in inherited colon condition
Disease control Recruiting nowThis study tests an experimental drug called REC-4881 in 67 adults with familial adenomatous polyposis (FAP), a genetic condition that causes many polyps in the colon and small intestine. The goal is to see if the drug can safely reduce the number and size of polyps. The trial ha…
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 04:45 UTC
-
New daily pill hopes to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests an experimental daily pill, REC-1245, in 170 adults with advanced solid tumors or lymphomas that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors or slow their growth. Participants will take the pill…
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC